Found: 212
Select item for more details and to access through your institution.
Monitoring Response and Resistance to Treatment in Chronic Lymphocytic Leukemia.
- Published in:
- Cancers, 2024, v. 16, n. 11, p. 2049, doi. 10.3390/cancers16112049
- By:
- Publication type:
- Article
Current Therapeutic Sequencing in Chronic Lymphocytic Leukemia.
- Published in:
- Hematology Reports, 2024, v. 16, n. 2, p. 270, doi. 10.3390/hematolrep16020027
- By:
- Publication type:
- Article
Targeting BTK in B Cell Malignancies: From Mode of Action to Resistance Mechanisms.
- Published in:
- International Journal of Molecular Sciences, 2024, v. 25, n. 6, p. 3234, doi. 10.3390/ijms25063234
- By:
- Publication type:
- Article
New Frontiers in Monoclonal Antibodies for Relapsed/Refractory Diffuse Large B-Cell Lymphoma.
- Published in:
- Cancers, 2024, v. 16, n. 1, p. 187, doi. 10.3390/cancers16010187
- By:
- Publication type:
- Article
Patients' preferences for chronic lymphocytic leukemia treatment: The CHOICE study.
- Published in:
- Hematological Oncology, 2024, v. 42, n. 1, p. 1, doi. 10.1002/hon.3216
- By:
- Publication type:
- Article
Venetoclax with Hypomethylating Agents in Newly Diagnosed Acute Myeloid Leukemia: A Systematic Review and Meta-Analysis of Survival Data from Real-World Studies.
- Published in:
- Cancers, 2023, v. 15, n. 18, p. 4618, doi. 10.3390/cancers15184618
- By:
- Publication type:
- Article
High BECN1 Expression Negatively Correlates with BCL2 Expression and Predicts Better Prognosis in Diffuse Large B-Cell Lymphoma: Role of Autophagy.
- Published in:
- Cells (2073-4409), 2023, v. 12, n. 15, p. 1924, doi. 10.3390/cells12151924
- By:
- Publication type:
- Article
Treatment Refractoriness in Chronic Lymphocytic Leukemia: Old and New Molecular Biomarkers.
- Published in:
- International Journal of Molecular Sciences, 2023, v. 24, n. 12, p. 10374, doi. 10.3390/ijms241210374
- By:
- Publication type:
- Article
Liquid biopsy in hematological malignancies: current and future applications.
- Published in:
- Frontiers in Oncology, 2023, p. 1, doi. 10.3389/fonc.2023.1164517
- By:
- Publication type:
- Article
Immunological Aspects of Richter Syndrome: From Immune Dysfunction to Immunotherapy.
- Published in:
- Cancers, 2023, v. 15, n. 4, p. 1015, doi. 10.3390/cancers15041015
- By:
- Publication type:
- Article
Anatomical heterogeneity of residual disease in chronic lymphocytic leukemia treated with ibrutinib.
- Published in:
- Hematological Oncology, 2022, v. 40, n. 5, p. 1105, doi. 10.1002/hon.3039
- By:
- Publication type:
- Article
Induction of robust humoral immunity against SARS‐CoV‐2 after vaccine administration in previously infected haematological cancer patients.
- Published in:
- British Journal of Haematology, 2022, v. 199, n. 3, p. 463, doi. 10.1111/bjh.18429
- By:
- Publication type:
- Article
Richter Syndrome: From Molecular Pathogenesis to Druggable Targets.
- Published in:
- Cancers, 2022, v. 14, n. 19, p. 4644, doi. 10.3390/cancers14194644
- By:
- Publication type:
- Article
Clonally unrelated Richter syndrome are truly de novo diffuse large B‐cell lymphomas with a mutational profile reminiscent of clonally related Richter syndrome.
- Published in:
- British Journal of Haematology, 2022, v. 198, n. 6, p. 1016, doi. 10.1111/bjh.18352
- By:
- Publication type:
- Article
New Frontiers in Monoclonal Antibodies for the Targeted Therapy of Acute Myeloid Leukemia and Myelodysplastic Syndromes.
- Published in:
- International Journal of Molecular Sciences, 2022, v. 23, n. 14, p. 7542, doi. 10.3390/ijms23147542
- By:
- Publication type:
- Article
Updated revision of the British Society of Haematology guidelines for chronic lymphocytic leukaemia.
- Published in:
- British Journal of Haematology, 2022, v. 197, n. 5, p. 513, doi. 10.1111/bjh.18119
- By:
- Publication type:
- Article
A leukemia-protective germline variant mediates chromatin module formation via transcription factor nucleation.
- Published in:
- Nature Communications, 2022, v. 13, n. 1, p. 1, doi. 10.1038/s41467-022-29625-6
- By:
- Publication type:
- Article
Elastin MIcrofibriL INterfacer1 (EMILIN‐1) is an alternative prosurvival VLA‐4 ligand in chronic lymphocytic leukemia.
- Published in:
- Hematological Oncology, 2022, v. 40, n. 2, p. 181, doi. 10.1002/hon.2947
- By:
- Publication type:
- Article
Inducible T‐cell co‐stimulator (ICOS) and ICOS ligand are novel players in the multiple‐myeloma microenvironment.
- Published in:
- British Journal of Haematology, 2022, v. 196, n. 6, p. 1369, doi. 10.1111/bjh.17968
- By:
- Publication type:
- Article
Prognostic impact of TP53 mutation in newly diagnosed diffuse large B‐cell lymphoma patients treated in the FIL‐DLCL04 trial.
- Published in:
- British Journal of Haematology, 2022, v. 196, n. 5, p. 1184, doi. 10.1111/bjh.17971
- By:
- Publication type:
- Article
Druggable Molecular Pathways in Chronic Lymphocytic Leukemia.
- Published in:
- Life (2075-1729), 2022, v. 12, n. 2, p. N.PAG, doi. 10.3390/life12020283
- By:
- Publication type:
- Article
Safety and Efficacy of Subcutaneous Rituximab in Previously Untreated Patients with CD20+ Diffuse Large B-Cell Lymphoma or Follicular Lymphoma: Results from an Italian Phase IIIb Study.
- Published in:
- Advances in Hematology, 2022, p. 1, doi. 10.1155/2022/5581772
- By:
- Publication type:
- Article
Patterns of neutralizing humoral response to SARS-CoV-2 infection among hematologic malignancy patients reveal a robust immune response in anti-cancer therapy-naive patients.
- Published in:
- Blood Cancer Journal, 2022, v. 12, n. 1, p. 1, doi. 10.1038/s41408-022-00608-6
- By:
- Publication type:
- Article
Efficacy of Front-Line Ibrutinib and Rituximab Combination and the Impact of Treatment Discontinuation in Unfit Patients with Chronic Lymphocytic Leukemia: Results of the Gimema LLC1114 Study.
- Published in:
- Cancers, 2022, v. 14, n. 1, p. 207, doi. 10.3390/cancers14010207
- By:
- Publication type:
- Article
Results of a randomized phase 3 study of oral sapacitabine in elderly patients with newly diagnosed acute myeloid leukemia (SEAMLESS).
- Published in:
- Cancer (0008543X), 2021, v. 127, n. 23, p. 4421, doi. 10.1002/cncr.33828
- By:
- Publication type:
- Article
IRF4 L116R mutation promotes proliferation of chronic lymphocytic leukemia B cells inducing MYC.
- Published in:
- Hematological Oncology, 2021, v. 39, n. 5, p. 707, doi. 10.1002/hon.2915
- By:
- Publication type:
- Article
Precision Medicine in Systemic Mastocytosis.
- Published in:
- Medicina (1010660X), 2021, v. 57, n. 11, p. 1, doi. 10.3390/medicina57111135
- By:
- Publication type:
- Article
Stiffer Spleen Predicts Higher Bone Marrow Fibrosis and Higher JAK2 Allele Burden in Patients With Myeloproliferative Neoplasms.
- Published in:
- Frontiers in Oncology, 2021, v. 11, p. 1, doi. 10.3389/fonc.2021.777730
- By:
- Publication type:
- Article
Multiregional sequencing and circulating tumour DNA analysis provide complementary approaches for comprehensive disease profiling of small lymphocytic lymphoma.
- Published in:
- British Journal of Haematology, 2021, v. 195, n. 1, p. 108, doi. 10.1111/bjh.17718
- By:
- Publication type:
- Article
Efficacy of idelalisib and rituximab in relapsed/refractory chronic lymphocytic leukemia treated outside of clinical trials. A report of the Gimema Working Group.
- Published in:
- Hematological Oncology, 2021, v. 39, n. 3, p. 326, doi. 10.1002/hon.2861
- By:
- Publication type:
- Article
A randomized clinical study on the impact of Comprehensive Geriatric Assessment (CGA) based interventions on the quality of life of elderly, frail, onco-hematologic patients candidate to anticancer therapy: protocol of the ONCO-Aging study.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Simple Parameters from Complete Blood Count Predict In-Hospital Mortality in COVID-19.
- Published in:
- Disease Markers, 2021, p. 1, doi. 10.1155/2021/8863053
- By:
- Publication type:
- Article
Octogenarian newly diagnosed multiple myeloma patients without geriatric impairments: the role of age >80 in the IMWG frailty score.
- Published in:
- 2021
- By:
- Publication type:
- Letter
Genetic Predisposition to Myelodysplastic Syndromes: A Challenge for Adult Hematologists.
- Published in:
- International Journal of Molecular Sciences, 2021, v. 22, n. 5, p. 2525, doi. 10.3390/ijms22052525
- By:
- Publication type:
- Article
An acquired factor V inhibitor induced uncontrolled bleeding in a postsurgery patient.
- Published in:
- Clinical Case Reports, 2021, v. 9, n. 1, p. 98, doi. 10.1002/ccr3.3452
- By:
- Publication type:
- Article
Cerebrospinal fluid xanthochromia after pegasparaginase hepatotoxicity in B‐cell acute lymphoblastic leukemia.
- Published in:
- Clinical Case Reports, 2020, v. 8, n. 11, p. 2293, doi. 10.1002/ccr3.3114
- By:
- Publication type:
- Article
Atypical Chronic Myeloid Leukemia: Where Are We Now?
- Published in:
- International Journal of Molecular Sciences, 2020, v. 21, n. 18, p. 6862, doi. 10.3390/ijms21186862
- By:
- Publication type:
- Article
Frequency and clinical relevance of coding and noncoding NOTCH1 mutations in early stage Binet A chronic lymphocytic leukemia patients.
- Published in:
- 2020
- By:
- Publication type:
- letter
Prognostic Significance of PET/CT in Patients with Chronic Lymphocytic Leukemia (CLL) Treated with Frontline Chemoimmunotherapy.
- Published in:
- Cancers, 2020, v. 12, n. 7, p. 1773, doi. 10.3390/cancers12071773
- By:
- Publication type:
- Article
Redefining the prognostic likelihood of chronic lymphocytic leukaemia patients with borderline percentage of immunoglobulin variable heavy chain region mutations.
- Published in:
- British Journal of Haematology, 2020, v. 189, n. 5, p. 853, doi. 10.1111/bjh.16434
- By:
- Publication type:
- Article
Anti-rasburicase antibodies induce clinical refractoriness by inhibiting the enzyme catalytic activity.
- Published in:
- 2020
- By:
- Publication type:
- case study
Precision Medicine Management of Chronic Lymphocytic Leukemia.
- Published in:
- Cancers, 2020, v. 12, n. 3, p. 642, doi. 10.3390/cancers12030642
- By:
- Publication type:
- Article
Consistency matters: measurement invariance of the EORTC QLQ-C30 questionnaire in patients with hematologic malignancies.
- Published in:
- 2020
- By:
- Publication type:
- Journal Article
Late relapse in patients with diffuse large B‐cell lymphoma: impact of rituximab on their incidence and outcome.
- Published in:
- British Journal of Haematology, 2019, v. 187, n. 4, p. 478, doi. 10.1111/bjh.16106
- By:
- Publication type:
- Article
Effect of Recombinant Zoster Vaccine on Incidence of Herpes Zoster After Autologous Stem Cell Transplantation: A Randomized Clinical Trial.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Integrated epigenomic and transcriptomic analysis reveals TP63 as a novel player in clinically aggressive chronic lymphocytic leukemia.
- Published in:
- International Journal of Cancer, 2019, v. 144, n. 11, p. 2695, doi. 10.1002/ijc.31999
- By:
- Publication type:
- Article
Digital PCR improves the quantitation of DMR and the selection of CML candidates to TKIs discontinuation.
- Published in:
- Cancer Medicine, 2019, v. 8, n. 5, p. 2041, doi. 10.1002/cam4.2087
- By:
- Publication type:
- Article
Genomic alterations of ribosomal protein genes in diffuse large B cell lymphoma.
- Published in:
- British Journal of Haematology, 2019, v. 185, n. 2, p. 330, doi. 10.1111/bjh.15442
- By:
- Publication type:
- Article
Unravelling the suboptimal response of TP53‐mutated chronic lymphocytic leukaemia to ibrutinib.
- Published in:
- British Journal of Haematology, 2019, v. 184, n. 3, p. 392, doi. 10.1111/bjh.15613
- By:
- Publication type:
- Article
Population-based outcome analysis of diffuse large B-cell lymphoma in people living with HIV infection and competent individuals.
- Published in:
- 2018
- By:
- Publication type:
- journal article